Natco Pharma Ltd

NSE: NATCOPHARM · BSE: 524816 · Pharmaceuticals & Biotechnology · 36 announcements

Share price: ₹810.10
Market cap: ₹15,892 Cr
Revenue (annual): ₹4,078 Cr
Net profit (annual): ₹1,418 Cr
P/E (TTM): 13.9×Sector 47.3×
Promoter holding: 49.42%+0.00% QoQ
FII holding: 16.99%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

14 Aug 2026 14:13 IST NSE

Natco Pharma Q1 FY27 Results: Net Profit ₹206.5 Cr, Down 57.0% YoY

Natco Pharma Ltd reported revenue from operations of ₹735.2 Cr (-44.7% YoY) and net profit of ₹206.5 Cr (-57.0% YoY) for Q1 FY27.

Key figure: Net profit ₹206.5 Cr · -57.0% YoY

Open full results → Read the filing ↗

29 May 2026 14:18 IST BSE

Financial Results

Natco Pharma Q4 FY26 Results: Net Profit ₹269 Cr, Down 33.7% YoY

Natco Pharma Ltd reported revenue from operations of ₹739.1 Cr (-39.5% YoY) and net profit of ₹269 Cr (-33.7% YoY) for Q4 FY26.

Key figure: Net profit ₹269 Cr · -33.7% YoY

Open full results → Read the filing ↗

29 May 2026 14:16 IST BSE

Financial Results

Natco Pharma Financial Results

Natco Pharma approved audited FY26 financial results, reporting consolidated total revenue of ₹4,375.9 Crore. The Board also amended CSR and fair disclosure policies.

Read the filing ↗